FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076994429> ?p ?o ?g. }

• W2076994429 endingPage "378" @default.
• W2076994429 startingPage "371" @default.
• W2076994429 abstract "Behavioral and electrophysiological evidence implicating the GABA-benzodiazepine receptor complex in the pathogenesis of hepatic encephalopathy was obtained using an improved rat model of hepatic encephalopathy caused by thioacetamide-induced fulminant hepatic failure. After the administration of thioacetamide together with supportive therapy, acute hepatocellular failure developed in rats as a result of massive hepatocellular necrosis without evidence of renal failure or hypoglycemia. The evolution of hepatic encephalopthy in this model was sufficiently slow to readily permit the staging of the syndrome. Prominent features of the encephalopathy include a marked reduction in open field activity and an abnormal visual evoked response. Both the deficits in spontaneous motor function and visual evoked response abnormalities of rats in stages III to IV hepatic encephalopathy were significantly improved after the administration of the benzodiazepine receptor ligands flumazenil or Ro 15-4513. Doses of flumazenil or Ro 15-4513 that produced these effects in rats with hepatic encephalopathy had no detectable action on either the behavior or the visual evoked responses of normal rats. The ability of benzodiazepine receptor ligands to ameliorate both the behavioral depression and the visual evoked response abnormalities associated with hepatic encephalopathy in the thioacetamide-induced rat model suggest an involvement of the GABA/benzodiazepine receptor complex in the pathogenesis of hepatic encephalopathy. In addition, the similarity of these observations to those in rabbits with hepatic encephalopathy caused by galactosamine-induced fulminant hepatic failure is compatible with the hypothesis that the mechanisms of hepatic encephalopathy in these two distinct models share a common final pathway, the allosteric enhancement of GABAergic tone through the benzodiazepine receptor. These observations suggest that increased concentrations or availability of a ligand with agonist properties at the benzodiazepine receptor may be involved in the pathogenesis of hepatic encephalopathy and that administration of benzodiazepine receptor antagonists may be of value in the management of hepatic encephalopathy in man. (HEPATOLOGY 1990; 11: 371–378.)" @default.
• W2076994429 created "2016-06-24" @default.
• W2076994429 creator A5031893972 @default.
• W2076994429 creator A5034829199 @default.
• W2076994429 creator A5037487051 @default.
• W2076994429 creator A5040741799 @default.
• W2076994429 creator A5053864071 @default.
• W2076994429 date "1990-03-01" @default.
• W2076994429 modified "2023-10-03" @default.
• W2076994429 title "Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands" @default.
• W2076994429 cites W1511285139 @default.
• W2076994429 cites W1514999705 @default.
• W2076994429 cites W1515404010 @default.
• W2076994429 cites W1537701079 @default.
• W2076994429 cites W1550491244 @default.
• W2076994429 cites W1605333679 @default.
• W2076994429 cites W1612149978 @default.
• W2076994429 cites W1772640160 @default.
• W2076994429 cites W1855448321 @default.
• W2076994429 cites W1978069924 @default.
• W2076994429 cites W1978342290 @default.
• W2076994429 cites W1980661175 @default.
• W2076994429 cites W1981436097 @default.
• W2076994429 cites W1985126447 @default.
• W2076994429 cites W1985224226 @default.
• W2076994429 cites W1991611883 @default.
• W2076994429 cites W1995964525 @default.
• W2076994429 cites W2001583156 @default.
• W2076994429 cites W2014066806 @default.
• W2076994429 cites W2030486888 @default.
• W2076994429 cites W2042232934 @default.
• W2076994429 cites W2046955343 @default.
• W2076994429 cites W2060497494 @default.
• W2076994429 cites W2061763682 @default.
• W2076994429 cites W2061767691 @default.
• W2076994429 cites W2066246075 @default.
• W2076994429 cites W2069340882 @default.
• W2076994429 cites W2073509178 @default.
• W2076994429 cites W2077190365 @default.
• W2076994429 cites W2093958535 @default.
• W2076994429 cites W2100835385 @default.
• W2076994429 cites W2141647944 @default.
• W2076994429 cites W4300710549 @default.
• W2076994429 cites W4317527911 @default.
• W2076994429 doi "https://doi.org/10.1002/hep.1840110307" @default.
• W2076994429 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2155865" @default.
• W2076994429 hasPublicationYear "1990" @default.
• W2076994429 type Work @default.
• W2076994429 sameAs 2076994429 @default.
• W2076994429 citedByCount "113" @default.
• W2076994429 countsByYear W20769944292012 @default.
• W2076994429 countsByYear W20769944292013 @default.
• W2076994429 countsByYear W20769944292014 @default.
• W2076994429 countsByYear W20769944292016 @default.
• W2076994429 countsByYear W20769944292017 @default.
• W2076994429 countsByYear W20769944292019 @default.
• W2076994429 countsByYear W20769944292020 @default.
• W2076994429 countsByYear W20769944292022 @default.
• W2076994429 countsByYear W20769944292023 @default.
• W2076994429 crossrefType "journal-article" @default.
• W2076994429 hasAuthorship W2076994429A5031893972 @default.
• W2076994429 hasAuthorship W2076994429A5034829199 @default.
• W2076994429 hasAuthorship W2076994429A5037487051 @default.
• W2076994429 hasAuthorship W2076994429A5040741799 @default.
• W2076994429 hasAuthorship W2076994429A5053864071 @default.
• W2076994429 hasBestOaLocation W20769944291 @default.
• W2076994429 hasConcept C126322002 @default.
• W2076994429 hasConcept C134018914 @default.
• W2076994429 hasConcept C168258287 @default.
• W2076994429 hasConcept C170493617 @default.
• W2076994429 hasConcept C2777214474 @default.
• W2076994429 hasConcept C2778173252 @default.
• W2076994429 hasConcept C2778409475 @default.
• W2076994429 hasConcept C2778621155 @default.
• W2076994429 hasConcept C2779609443 @default.
• W2076994429 hasConcept C2780325230 @default.
• W2076994429 hasConcept C2781057625 @default.
• W2076994429 hasConcept C2911091166 @default.
• W2076994429 hasConcept C2911118192 @default.
• W2076994429 hasConcept C71924100 @default.
• W2076994429 hasConcept C98274493 @default.
• W2076994429 hasConceptScore W2076994429C126322002 @default.
• W2076994429 hasConceptScore W2076994429C134018914 @default.
• W2076994429 hasConceptScore W2076994429C168258287 @default.
• W2076994429 hasConceptScore W2076994429C170493617 @default.
• W2076994429 hasConceptScore W2076994429C2777214474 @default.
• W2076994429 hasConceptScore W2076994429C2778173252 @default.
• W2076994429 hasConceptScore W2076994429C2778409475 @default.
• W2076994429 hasConceptScore W2076994429C2778621155 @default.
• W2076994429 hasConceptScore W2076994429C2779609443 @default.
• W2076994429 hasConceptScore W2076994429C2780325230 @default.
• W2076994429 hasConceptScore W2076994429C2781057625 @default.
• W2076994429 hasConceptScore W2076994429C2911091166 @default.
• W2076994429 hasConceptScore W2076994429C2911118192 @default.
• W2076994429 hasConceptScore W2076994429C71924100 @default.
• W2076994429 hasConceptScore W2076994429C98274493 @default.
• W2076994429 hasIssue "3" @default.
• W2076994429 hasLocation W20769944291 @default.

• next